2-Trifluoromethyldeschloroketamine

Trifluoromethyldeschloroketamine

Trifluoromethyldeschloroketamine

Chemical compound

Trifluoromethyldeschloroketamine (TFMDCK) is a designer drug from the arylcyclohexylamine family, which is presumed to have similar properties to ketamine, a dissociative anesthetic drug with hallucinogenic and sedative effects. It has been sold over the internet since around 2016, though genuine samples appear to be rare.[1] The o-trifluoromethyl analogue of hydroxynorketamine has also been researched as an antidepressant.[2]

Quick Facts Clinical data, ATC code ...

See also

References

  1. [1]
    Wallach J, Brandt SD (2018). "1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances". New Psychoactive Substances. Handbook of Experimental Pharmacology. Vol. 252. pp. 305–352. doi:10.1007/164_2018_148. ISBN 978-3-030-10560-0. PMID 30196446.
  2. [2]
    种长效化合物的制备方法. Chinese patent CN 110540510A, 18 June 2019



Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article 2-Trifluoromethyldeschloroketamine, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.